A carregar...

New Strategies in Neuroblastoma: Therapeutic Targeting of MYCN and ALK

Clinical outcome remains poor in high-risk neuroblastoma patients, where chemoresistant relapse is common following high-intensity conventional multimodal therapy. Novel treatment approaches are required. Although recent genomic profiling initiatives have not revealed a high frequency of mutations i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Barone, Giuseppe, Anderson, John, Pearson, Andrew D. J., Petrie, Kevin, Chesler, Louis
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3818140/
https://ncbi.nlm.nih.gov/pubmed/23965898
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0680
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!